Feng GS - Search Results

1

β-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β-catenin and MET.

Liang Y, Feng Y, Zong M, Wei XF, Lee J, Feng Y, Li H, Yang GS, Wu ZJ, Fu XD, Feng GS. Liang Y, et al. Among authors: feng y, feng gs. Hepatology. 2018 May;67(5):1807-1822. doi: 10.1002/hep.29661. Epub 2018 Apr 6. Hepatology. 2018. PMID: 29152756 Free PMC article.

2

p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathways.

Fu J, Chen Y, Cao J, Luo T, Qian YW, Yang W, Ren YB, Su B, Cao GW, Yang Y, Yan YQ, Shen F, Wu MC, Feng GS, Wang HY. Fu J, et al. Among authors: feng gs. Hepatology. 2011 Jan;53(1):181-92. doi: 10.1002/hep.24015. Epub 2010 Dec 10. Hepatology. 2011. PMID: 21254169

3

Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.

Bard-Chapeau EA, Li S, Ding J, Zhang SS, Zhu HH, Princen F, Fang DD, Han T, Bailly-Maitre B, Poli V, Varki NM, Wang H, Feng GS. Bard-Chapeau EA, et al. Among authors: feng gs. Cancer Cell. 2011 May 17;19(5):629-39. doi: 10.1016/j.ccr.2011.03.023. Cancer Cell. 2011. PMID: 21575863 Free PMC article.

4

Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.

Sun W, Ding J, Wu K, Ning BF, Wen W, Sun HY, Han T, Huang L, Dong LW, Yang W, Deng X, Li Z, Wu MC, Feng GS, Xie WF, Wang HY. Sun W, et al. Among authors: feng gs. Hepatology. 2011 Oct;54(4):1259-72. doi: 10.1002/hep.24530. Hepatology. 2011. PMID: 21735473

5

Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.

Li L, Chen L, Hu L, Liu Y, Sun HY, Tang J, Hou YJ, Chang YX, Tu QQ, Feng GS, Shen F, Wu MC, Wang HY. Li L, et al. Among authors: feng gs. Hepatology. 2011 Nov;54(5):1620-30. doi: 10.1002/hep.24552. Epub 2011 Jul 25. Hepatology. 2011. PMID: 21809356

6

Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox.

Feng GS. Feng GS. Cancer Cell. 2012 Feb 14;21(2):150-4. doi: 10.1016/j.ccr.2012.01.001. Cancer Cell. 2012. PMID: 22340589 Free PMC article. Review.

7

OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.

Yang W, Wang C, Lin Y, Liu Q, Yu LX, Tang L, Yan HX, Fu J, Chen Y, Zhang HL, Tang L, Zheng LY, He YQ, Li YQ, Wu FQ, Zou SS, Li Z, Wu MC, Feng GS, Wang HY. Yang W, et al. Among authors: feng gs. J Hepatol. 2012 Sep;57(3):613-20. doi: 10.1016/j.jhep.2012.04.024. Epub 2012 May 19. J Hepatol. 2012. PMID: 22612999

8

Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis.

Li S, Hsu DD, Wang H, Feng GS. Li S, et al. Among authors: feng gs. Front Med. 2012 Sep;6(3):275-9. doi: 10.1007/s11684-012-0216-4. Epub 2012 Aug 6. Front Med. 2012. PMID: 22869052 Review.

9

Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.

Wu K, Ding J, Chen C, Sun W, Ning BF, Wen W, Huang L, Han T, Yang W, Wang C, Li Z, Wu MC, Feng GS, Xie WF, Wang HY. Wu K, et al. Among authors: feng gs. Hepatology. 2012 Dec;56(6):2255-67. doi: 10.1002/hep.26007. Hepatology. 2012. PMID: 22898879

10

PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.

Han T, Xiang DM, Sun W, Liu N, Sun HL, Wen W, Shen WF, Wang RY, Chen C, Wang X, Cheng Z, Li HY, Wu MC, Cong WM, Feng GS, Ding J, Wang HY. Han T, et al. Among authors: feng gs. J Hepatol. 2015 Sep;63(3):651-60. doi: 10.1016/j.jhep.2015.03.036. Epub 2015 Apr 9. J Hepatol. 2015. PMID: 25865556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters